Skip to content

Discontinued — last reported Q4 '20

Operating margin at other companies

Amgen logo
AmgenAMGN
28.4%+6.6pp
Incyte logo
IncyteINCY
30%+26.1pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-206.2%-61.0pp
CG Oncology logo
CG OncologyCGON
-4,239%-1,872pp
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-2,776.6%-820pp
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-15,754.2%-17,253pp

Other financials

Income statement

See full
Operating income-$103.6M-38.3%
Net income-$97.4M-35.2%
EPS (diluted)-$0.53-1.9%

Balance sheet

See full
Cash & equivalents$241.2M+91.4%
Total debt$15.5M-9.4%
Total equity$607.7M+177%
Total assets$903.0M+218%

Cash flow

See full
Operating cash flow-$86.9M-30.6%
CapEx$449.0K-17.9%
Free cash flow-$87.3M-30.2%

Valuation

See full
Market cap$5.9B+816%

Profitability

See full
Net margin-950.4%
FCF margin-184.7%

Returns & leverage

See full
Return on equity-85.7%+1.7pp
Debt / equity-0.1×
Current ratio15.1×+10.0×

Where this comes from

Calculated from Cogent Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Cogent Biosciences, Inc.’s 10-K, filed March 15, 2022, on SEC EDGAR. View the filing →

Questions, answered.

What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.